Registration and breakfast

​

Welcome and Overview of Eyecelerator @ Park City 2025​

​​

• Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology 

• Gil Kliman, MD, MBA, Program Director

• Allen C. Ho, MD, Retina Program Director

​​​Moderator: Gil Kliman, MD, MBA, Program Director

​

​Speakers: 

• Kristen Harmon Ingenito, MBA, CEO, Market Scope

• Jeff Weinhuff, MBA, Managing Partner, Visionary Ventures

• Andrew Gitkin, Senior Managing Director, Healthcare Investment Banking, Leerink Partners LLC​

​

​Panel: 

• Andrew Gitkin, Senior Managing Director, Healthcare Investment Banking, Leerink Partners LLC

• Kristen Harmon Ingenito, MBA, CEO, Market Scope

• Doug Kelly, MD, MBA, Former Deputy Center Director for Science, Chief Scientist, Center for Devices & Radiological Health (CDRH), FDA

• Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology

• Zach Scheiner, PhD, Principal, RA Capital Management, L.P.

• Jeff Weinhuff, MBA, Managing Partner, Visionary Venture Fund​​

​​​Moderators: 

• Jonathan Li, MD, Program Co-Chair

• Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology

​

​Introduction to Myopia & Control Modalities: Jonathan Li, MD, Program Co-Chair

​

The Myopia Market as We See It: Rupe Hansra, OD, Vice President, Professional Affairs, Topcon Healthcare​

​

Optical Solutions for Myopia Control: Olga Prenat, MSc, Global Head of Medical Affairs, EssilorLuxottica 

Panel: 

• ​Rupe Hansra, OD, Vice President, Professional Affairs, Topcon Healthcare

• Patrick Johnson, PhD, President, Sydnexis

• Olga Prenat, MSc, Global Head of Medical Affairs, EssilorLuxottica

• Matthew Rickard, Professor of Biomedical Engineering, California Baptist University, Co-Founder, Blink Frames

• Daniel Ting, MBBS (Hons), M Med (Ophth), PhD, Senior Consultant, Singapore National Eye Centre

Networking Break 
 

​Moderators: 

• Rajesh K. Rajpal, MD, Program Co-Chair

• Christine W. Sindt, OD, Professor, Clinical Ophthalmology, University of Iowa

​

​Panel: 

• Michael Ackermann, PhD, CEO, Osanni Bio, Inc.

• Patricia Buehler, MD, MPH, Founder and CEO, Osheru

• Doug Fisher, MD, MBA, Partner, Revelation Partners

• Rob Scott, PhD, MS, Vice President, Intraocular Devices R&D, Alcon

​Moderators: 

• Susana Marcos, PhD, Director, Center for Visual Science, University of Rochester, Co-Founder, 2EyesVision

• ​Vance Thompson, MD, Vance Thompson Vision

​​​

Panel:

• Dimitri Azar, MD, MBA, President and CEO, Lacristat.AI

• Ben Bergo, MA, President & Chief Business Officer, Tenpoint Therapeutics, Ltd. 

• Keith Holliday, PhD, Former Chief Technology Officer, STAAR Surgical

• ​Terry Kim, MD, Chief Medical Officer, Alcon

• Kristine Morrill, Founder & President, Medevise Consulting SAS

Enjoy a bite to eat with your colleagues.
 

​Glaucoma Moderator: Kuldev Singh, MD, MPH, Program Co-Chair

Panel: 

• Randy Craven, MD, Senior Medical Director, Eyecare, Research and Development, AbbVie Inc.

• ​Anthony Khawaja, PhD, MA, Professor, Moorfields Eye Hospital & University College London

• Cody McKenzie, VP, Global Marketing Strategy & Franchise Management, Glaukos 

• Barbara Wirostko, MD, Adjunct Professor, Ophthalmology & Biomedical Engineering, University of Utah & Co-Founder, Qlaris Bio, Inc.

​

Retina In Office Moderators: 

• Robert L. Avery, MD, Program Co-Chair

• Lejla Vajzovic, MD, Professor of Ophthalmology, Duke University School of Medicine

Panel: 

• Samuel Barone, MD, Chief Medical Officer, Nanoscope

• Dhaval Desai, PharmD, Chief Development Officer, 4DMT

• Michael J. O'Rourke, CEO, RE-Vana Therapeutics

• Ramiro Ribeiro, MD, PhD, Chief Medical Officer, EyePoint Pharmaceuticals, Inc.

• Peter Soparkar, COO, Adverum Biotechnologies, Inc.

• ​Nadia K. Waheed, MD, MPH, Chief Medical Officer, Ocular Therapeutix, Inc. 

​

Retina In OR Moderators: 

• Allen C. Ho, MD, Retina Program Director

• Namrata Saroj, OD, Chief Business Officer, Ocular Therapeutix, Inc.

Panel: 

• Brian Culley, CEO, Lineage Cell Therapeutics

• Mark Humayun, MD, PhD, Professor of Ophthalmology, University of Southern California

• Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer, REGENEXBIO, Inc.

• Dante J. Pieramici, MD, Medical Director of Clinical Research, California Retina Associates

• Rich Small, CEO, Neurotech Pharmaceuticals, Inc.​​

Thirty-seven companies present innovative new treatments, products, and services. Three breakout rooms will operate simultaneously for each segment. Links for showcase schedules are below:

​

Anterior Segment and Glaucoma -  Room: Deer Creek Ballroom 

Retina: Gene Therapy and Novel Mechanisms of Action - Room: Strawberry Ballroom

Retina: TKI and Drug Delivery - Room: Jordanelle Ballroom A

Networking Break ​

​Moderators:

• Robert L. Avery, MD, Program Co-Chair

• Allen C. Ho, MD, Retina Program Director

• Kuldev Singh, MD, MPH, Program Co-Chair

Panel:

​​

• Samuel Barone, MD, Chief Medical Officer, Nanoscope Therapeutics

• Art Ciociola, PhD, Principal Member, Ciociola Regulatory Consultancy, LLC

• Malvina Eydelman, MD, CEO, Collaborative Community on Ophthalmic Innovation (CCOI)

• Doug Kelly, MD, MBA, Former Deputy Center Director for Science, Chief Scientist, Center for Devices & Radiological Health (CDRH), FDA

The program committee wraps the day with the People's Choice recognition of best presenting company by segment.  

Enjoy refreshments and connect!

​